LGT Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $277K | Buy |
1,495
+68
| +5% | +$12.6K | 0.7% | 32 |
|
2025
Q1 | $299K | Sell |
1,427
-349
| -20% | -$73.1K | 0.91% | 28 |
|
2024
Q4 | $316K | Buy |
1,776
+11
| +0.6% | +$1.95K | 0.7% | 27 |
|
2024
Q3 | $348K | Sell |
1,765
-663
| -27% | -$131K | 0.86% | 27 |
|
2024
Q2 | $416K | Sell |
2,428
-336
| -12% | -$57.6K | 0.88% | 24 |
|
2024
Q1 | $503K | Buy |
2,764
+19
| +0.7% | +$3.46K | 0.58% | 32 |
|
2023
Q4 | $425K | Sell |
2,745
-241
| -8% | -$37.3K | 0.52% | 38 |
|
2023
Q3 | $445K | Sell |
2,986
-480
| -14% | -$71.6K | 0.57% | 29 |
|
2023
Q2 | $467K | Buy |
3,466
+522
| +18% | +$70.3K | 0.5% | 53 |
|
2023
Q1 | $469K | Buy |
2,944
+21
| +0.7% | +$3.35K | 0.87% | 20 |
|
2022
Q4 | $472K | Buy |
+2,923
| New | +$472K | 0.56% | 35 |
|